Pharmacology of excitatory amino acid transporters (EAATs and VGLUTs)

Folia Pharmacologica Japonica

Volumn 122, Issue 3, 2003, Pages 253-264

  Shigeri, Yasushi ^a   Shimamoto, Keiko ^b  

^a NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^b SUNTORY INSTITUTE FOR BIOORGANIC RESEARCH   (Japan)

Author keywords

EAAT; Excitatory neurotransmitter; Glutamate; Glutamate transporter; VGLUT

Indexed keywords

(CARBOXYCYCLOPROPYL)GLYCINE; 2 PHENYLOXAZOLINE 2,5 DICARBOXYLIC ACID; 4 METHYLGLUTAMIC ACID; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; AMINO ACID TRANSPORTER; BROMOCRIPTINE; DICARBOXYLIC ACID DERIVATIVE; DIHYDROKAINIC ACID; EVANS BLUE; GLUTAMATE TRANSPORTER; GLUTAMIC ACID DERIVATIVE; GLYCINE DERIVATIVE; HORMONE RECEPTOR AFFECTING AGENT; KAINIC ACID; KYNURENIC ACID; PYRROLIDINE DICARBOXYLATE; QUINOLINE 2,4 DICARBOXYLIC ACID; ROSE BENGAL; SERINE; SERINE SULFATE; SODIUM DEPENDENT GLUTAMATE TRANSPORTER; THREO 3 METHYLGLUTAMIC ACID; UNCLASSIFIED DRUG; XANTHURENIC ACID;

ALZHEIMER DISEASE; AMINO ACID TRANSPORT; AMYOTROPHIC LATERAL SCLEROSIS; BRAIN ISCHEMIA; DRUG MECHANISM; DRUG STRUCTURE; EXTRACELLULAR SPACE; HORMONE SYNTHESIS; HUNTINGTON CHOREA; LEARNING; MEMORY; NERVE CELL PLASTICITY; NEUROTRANSMISSION; NEUROTRANSMITTER RELEASE; NONHUMAN; PROTEIN FUNCTION; RECEPTOR INTRINSIC ACTIVITY; REVIEW; SYNAPTIC TRANSMISSION;

AMINO ACID TRANSPORT SYSTEM X-AG; ANIMALS; DRUG DESIGN; GLUTAMIC ACID; HUMANS; LEARNING; MEMORY; NEURODEGENERATIVE DISEASES; NEURONAL PLASTICITY; SYNAPTIC TRANSMISSION;

EID: 0141703333     PISSN: 00155691     EISSN: None     Source Type: Journal    
DOI: 10.1254/fpj.122.253     Document Type: Review

References (61)

1. Seal RP, Amara SG. Excitatory amino acid transporters: a family in flux. Ann Rev Pharmacol Toxicol. 1999;39:431-456.
2. Danbolt NC. Glutamate uptake. Prog Neurobiol. 2001;65:1-105.
3. +-dependent glutamate/aspartate transporter from rat brain. Proc Natl Acad Sci USA. 1992;89:10955-10959.
4. Pines G, Danbolt NC, Bjoras M, et al. Cloning and expression of a rat brain L-glutamate transporter. Nature. 1992;360:464-467.
5. Kanai Y, Hediger MA. Primary structure and functional characterization of a high-affinity glutamate transporter. Nature. 1992;360:467-471.
6. Arriza JL, Fairman WA, Wadiche J, et al. Functional comparisons of three glutamate transporter subtypes cloned from motor cortex. J Neurosci. 1994;14:5559-5569.
7. Fairman WA, Vandenberg RJ, Arriza JL, et al. An excitatory amino-acid transporter with properties of a ligand-gated chloride channel. Nature. 1995; 375:599-603.
8. Arriza JL, Eliasof S, Kavanaugh MP, et al. Excitatory amino acid transporter 5, a retinal glutamate transporter coupled to a chloride conductance. Proc Natl Acad Sci USA. 1997;94:4155-4160.
9. Ozkan ED, Ueda T. Glutamate transport and storage in synaptic vesicles. Jpn J Pharmacol. 1998;77: 1-10.
10. Bellocchio EE, Reimer RJ, Fremeau RT, et al. Uptake of glutamate into synaptic vesicles by an inorganic phosphate transporter. Science. 2000;289:957-960.
11. Takamori S, Rhee JS, Rosenmund C, et al. Identification of a vesicular glutamate transporter that defines a glutamatergic phenotype in neurons. Nature. 2000;407:189-194.
12. Fremeau RT Jr, Troyer MD, Pahner I, et al. The expression of vesicular glutamate transporters defines two classes of excitatory synapse. Neuron. 2001;31:247-260.
13. Herzog E, Bellenchi GC, Gras C, et al. The existence of a second vesicular glutamate transporter specifies subpopulations of glutamatergic neurons. J Neurosci. 2001;21:RC181 1-6.
14. Takamori S, Rhee JS, Rosenmund C, et al. Identification of differentiation-associated brain-specific phosphate transporter as a second vesicular glutamate transporter (VGLUT2). J Neurosci. 2001;21: RC182 1-6.
15. +/PI transporter as a novel vesicular glutamate transporter expressed in a distinct set of glutamatergic synapses. J Neurosci. 2002;22:142-155.
16. Gras C, Herzog E, Bellenchi GC, et al. A third vesicular glutamate transporter expressed by cholinergic and serotoninergic neurons. J Neurosci. 2002; 22:5442-5451.
17. Takamori S, Malherbe P, Broger C, et al. Molecular cloning and functional characterization of human vesicular glutamate transporter 3. EMBO Rep. 2002;3:798-803.
18. Fremeau RT Jr, Burman J, Qureshi T, et al. The identification of vesicular glutamate transporter 3 suggests novel modes of signaling by glutamate. Proc Natl Acad Sci USA. 2002;99:14488-14493.
19. Schafer MK, Varoqui H, Defamie N, et al. Molecular cloning and functional identification of mouse vesicular glutamate transporter 3 and its expression in subsets of novel excitatory neurons. J Biol Chem. 2002;277:50734-50748.
20. Leighton BH, Seal RP, Shimamoto K, et al. A hydrophobic domain in glutamate transporters forms an extracellular helix associated with the permeation pathway for substrates. J Biol Chem. 2002;277: 29847-29855.
21. Kanner BI, Borre L. The dual-function glutamate transporters: structure and molecular characterisation of the substrate-binding sites. Biochim Biophys Acta 2002;1555:92-95.
22. Eskandari S, Kreman M, Kavanaugh MP, et al. Pentameric assembly of a neuronal glutamate transporter. Proc Natl Acad Sci USA. 2000;97:8641-8646.
23. Bergles D, Tzingounis AV, Jahr C. Comparison of coupled and uncoupled currents during glutamate uptake by GLT-1 transporters. J Neurosci. 2002;22: 10153-10162.
24. Lin CI, Orlov I, Ruggiero AM, et al. Modulation of the neuronal glutamate transporter EAAC1 by the interacting protein GTRAP3-18. Nature. 2001;410: 84-88.
25. Jackson M, Song W, Liu MY, et al. Modulation of the neuronal glutamate transporter EAAT4 by two interacting proteins. Nature. 2001;410:89-93.
26. Ikemoto MJ, Inoue K, Akiduki S, et al. Identification of addicsin/GTRAP3-18 as a chronic morphine-augmented gene in amygdala. Neuroreport. 2002;13:2079-2084.
27. Tanaka K, Watase K, Manabe T, et al. Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science. 1997; 276:1699-1702.
28. Munch C, Ebstein M, Seefried U, et al. Alternative splicing of the 5′-sequences of the mouse EAAT2 glutamate transporter and expression in a transgenic model for amyotrophic lateral sclerosis. J Neurochem. 2002;82:594-603.
29. Robinson MB. Regulated trafficking of neurotransmitter transporters: common notes but different melodies. J. Neurochem. 2002;80:1-11.
30. Kalandadze A, Wu Y, Robinson MB. Protein kinase C activation decreases cell surface expression of the GLT-1 subtype of glutamate transporter. Requirement of a carboxyl-terminal domain and partial dependence on serine 486. J Biol Chem. 2002;277:45741-45750.
31. Sims KD, Straff DJ, Robinson MB. Platelet-derived growth factor rapidly increases activity and cell surface expression of the EAAC1 subtype of glutamate transporter through activation of phosphatidylinositol 3-kinase. J Biol Chem. 2000;275:5228-5237.
32. Fairman WA, Sonders MS, Murdoch GH, et al. Arachidonic acid elicits a substrate-gated proton current associated with the glutamate transporter EAAT4. Nature Neurosci. 1998;1:105-113.
33. Tzingounis AV, Lin CL, Rothstein JD, et al. Arachidonic acid activates a proton current in the rat glutamate transporter EAAT4. J Biol Chem. 1998; 273:17315-17317.
34. Shimada F, Shiga Y, Morikawa M, et al. The neuroprotective agent MS-153 stimulates glutamate uptake. Eur J Pharmacol. 1999;386:263-270.
35. 2+ increase. Eur J Pharmacol. 1992;211:195-202.
36. Nakamura Y, Kataoka K, Ishida M, et al. (2S,3S,4R)-2-(carboxycyclopropyl) glycine, a potent and competitive inhibitor of both glial and neuronal uptake of glutamate. Neuropharmacology. 1993;32: 833-837.
37. Shimamoto K, Ohfune Y. Syntheses and conformational analyses of glutamate analogs: 2-(2-carboxy-3-substituted-cyclopropyl)glycines as useful probes for excitatory amino acid receptors. J Med Chem. 1996;39:407-423.
38. Shimamoto K, Lebrun B, Yasuda-Kamatani Y, et al. DL-threo-beta-benzyloxyaspartate, a potent blocker of excitatory amino acid transporters. Mol Pharmacol. 1998;53:195-201.
39. Vandenberg RJ, Mitrovic AD, Chebib M, et al. Contrasting modes of action of methylglutamate derivatives on the excitatory amino acid transporters, EAAT1 and EAAT2. Mol Pharmacol. 1997;51: 809-815.
40. Dingledine R, Borges K, Bowie D, et al. The glutamate receptor ion channels. Pharmacol Rev. 1999; 51:7-61.
41. Brauner-Osborne H, Hermit MB, Nielsen B, et al. A new structural class of subtype-selective inhibitor of cloned excitatory amino acid transporter, EAAT2. Eur J Pharmacol. 2000;406:41-44.
42. Koch HP, Kavanaugh MP, Esslinger CS, et al. Differentiation of substrate and nonsubstrate inhibitors of the high-affinity, sodium-dependent glutamate transporters. Mol Pharmacol. 1999;6:1095-1104.
43. Vandenberg RJ, Mitrovic AD, Johnston GA. Serine-O-sulphate transport by the human glutamate transporter, EAAT2. Br J Pharmacol. 1998; 123:1593-1600.
44. Lebrun B, Sakaitani M, Shimamoto K, et al. New beta-hydroxyaspartate derivatives are competitive blockers for the bovine glutamate/aspartate transporter. J Biol Chem. 1997;272:20336-20339.
45. Shimamoto K, Shigeri Y, Yasuda-Kamatani Y, et al. Syntheses of optically pure beta-hydroxyaspartate derivatives as glutamate transporter blockers. Bioorg Med Chem Lett. 2000;10:2407-2410.
46. Shigeri Y, Shimamoto K, Yasuda-Kamatani Y, et al. Effects of threo-beta-hydroxyaspartate derivatives on excitatory amino acid transporters (EAAT4 and EAAT5). J Neurochem. 2001;79:297-302.
47. Takaoka K, Tatsu Y, Yumoto N, et al. Synthesis and photoreactivity of caged blockers for glutamate transporters. Bioorg Med Chem Lett. 2003;13:965-970.
48. Campiani G, De Angelis M, Armaroli S, et al. A rational approach to the design of selective substrates and potent nontransportable inhibitors of the excitatory amino acid transporter EAAC1 (EAAT3). New glutamate and aspartate analogues as potential neuroprotective agents. J Med Chem. 2001;44:2507-2510.
49. Li JL, Fujiyama F, Kaneko T et al. Expression of vesicular glutamate transporters, VGluT1 and VGluT2, in axon terminals of nociceptive primary afferent fibers in the superficial layers of the medullary and spinal dorsal horns of the rat. J Comp Neurol. 2003;457:236-249.
50. Reimer RJ, Fremeau RT Jr, Bellocchio EE, et al. The essence of excitation. Curr Opin Cell Biol. 2001;13:417-421.
51. Ikemoto A, Bole DG, Ueda T. Glycolysis and glutamate accumulation into synaptic vesicles. J Biol Chem. 2003;278:5929-5940.
52. Winter HC, Ueda T. Glutamate uptake system in the presynaptic vesicle: glutamic acid analogs as inhibitors and alternate substrates. Neurochem Res. 1993;1:79-85.
53. Bartlett RD, Esslinger CS, Thompson CM, et al. Substituted quinolines as inhibitors of L-glutamate transport into synaptic vesicles. Neuropharmacology. 1998;37:839-846.
54. Carrigan CN, Esslinger CS, Bartlett RD, et al. Quinoline-2, 4-dicarboxylic acids: synthesis and evaluation as inhibitors of the glutamate vesicular transport system. Bioorg Med Chem Lett. 1999;9: 2607-2612.
55. Carrigan CN, Bartlett RD, Esslinger CS, et al. Synthesis and in vitro pharmacology of substituted quinoline-2,4-dicarboxylic acids as inhibitors of vesicular glutamate transport. J Med Chem. 2002;45: 2260-2276.
56. Roseth S, Fykse EM, Fonnum F. Uptake of L-glutamate into rat brain synaptic vesicles: effect of inhibitors that bind specifically to the glutamate transporter. J Neurochem. 1995;65:96-103.
57. Ogita K, Hirata K, Bole DG, et al. Inhibition of vesicular glutamate storage and exocytotic release by Rose Bengal. J Neurochem. 2001;77:34-42.
58. Carlson MD, Kish PE, Ueda T. Glutamate uptake into synaptic vesicles: competitive inhibition by bromocriptine. J Neurochem. 1989;53:1889-1894.
59. Moriyama Y, Amakatsu K, Yamada H, et al. Inhibition of neurotransmitter and hormone transport into secretory vesicles by 2-(4-phenylpiperidino)cyclohexanol and 2-bromo-alpha-ergocryptine: both compounds act as uncouplers and dissipate the electrochemical gradient of protons. Arch Biochem Biophys. 1991;290:233-238.
60. Ozkan ED, Lee FS, Ueda T. A protein factor that inhibits ATP-dependent glutamate and gamma-aminobutyric acid accumulation into synaptic vesicles: purification and initial characterization. Proc Natl Acad Sci USA. 1997;94:4137-4142.
61. 2+-dependent, evoked release of glutamate, GABA and serotonin. J Neurochem. 2001;76:1153-1164.